Title: Pharmacodynamics
1Pharmacodynamics
- Pharmacology 49.222
- Bill Diehl-Jones RN, PhD
- Faculty of Nursing and Department of Zoology
2Agenda
- Definitions
- Receptors, ligands, agonists and antagonists
- Receptors types
- Alpha and beta adrenoreceptors
- Receptor Up- and Down-Regulation
- Partial agonists, competitive/non-competitive
antagonists - Therapeutic Index
3Pharmacodynamics
4Major ConceptDrugs ultimately work at the
cellular level
5Major Concepts
- Drugs often work by binding to a receptor
- Receptors are found in the cell membrane, in the
cytoplasm, and in the nucleus - Anything that binds to a receptor is a ligand
6Once a ligand binds to a receptor, stuff
happens...
Ligand
Y
Receptor
? Cai
X
Z
7Not all drugs work on receptors
- Eg many anaesthetics affect the stability of the
plasma membrane - Others (such as caffeine!) affect the
biochemistry of cells
8Drug Receptors
- Agonists and antagonists
- Functions
- Receptor numbers and response
9So, what is a receptor agonist?
- Any drug that binds to a receptor and stimulates
the functional activities - eg adrenaline (epinephrine)
Some Effect
A Cell
10Types of Receptors
- Are they specific?
- usually, but not always
- Are there subtypes?
- sometimes
- example
- there are several types of epinephrine receptors
11There can be several types of receptors
Epinephrine
?1 Receptors in Heart
?2 Receptors in Bronchioles
12Some Questions
- 1. What is the effect of Beta receptor activation
in the heart?2. What is the effect of Beta
receptor activation in the lungs?Hint They
produce different effects. Why?
13A Problem
- Epinephrine is a non-specific drug it is an
agonist for BOTH ?1 and ?2 receptors - Why might this be a problem for someone with
asthma?
14A Solution
- More specific agonists have been developed
- eg terbutaline is a more specific ?2 agonist
that is used for treating people with asthma
15So, what is a receptor antagonist?
- Any drug that prevents the binding of an agonist
- eg propranolol (a beta blocker)
Propranolol
Dude, youre in my way!
Epinephrine
16Still More Problems
- Propranolol is a non-specific antagonist
- Giving propranolol can cause asthma
- Why?
17Any Solutions?
18Receptor Numbers and Responses
- The NUMBER and AFFINITY of receptors may change
- An increase in receptor number is called
UPREGULATION - A decrease in receptor number is called
DOWNREGULATION
19Eg Thyroid Hormone and Beta1 Receptors
- Eg Upregulation
- Thyroid hormone increases the number of cardiac
?1 receptors - Clinical relevance
- During thyrotoxicosis, Propranolol can be used
for treating tachycardia - why? Because propranolol will have enough ?1
receptors
20Eg Thyroid Hormone and Beta1 Receptors
- Eg Downregulation
- prolonged use of propranolol can DECREASE the
number of ?1 receptors - Clinical relevance
- A patients response to drug therapy may change
over time
21Receptor Numbers and Responses
- The NUMBER and AFFINITY of receptors may change
- An increase in receptor number is called
UPREGULATION - A decrease in receptor number is called
DOWNREGULATION
22Eg Thyroid Hormone and Beta1 Receptors
- Eg Upregulation
- Thyroid hormone increases the number of cardiac
?1 receptors - Clinical relevance
- During thyrotoxicosis, Propranolol can be used
for treating tachycardia - why? Because propranolol will have enough ?1
receptors
23Eg Thyroid Hormone and Beta1 Receptors
- Eg Downregulation
- prolonged use of propranolol can DECREASE the
number of ?1 receptors - Clinical relevance
- A patients response to drug therapy may change
over time
24New Concepts
- Competitive Antagonist
- both the drug and its antagonist compete for the
same receptor - Non-competitive Antagonist
- the drug and its antagonist do not compete for
the same receptor - Partial Agonist
- a drug which blocks the agonist site by causing a
lesser response - STAY TUNED!
25Bringing Pharmacodynamics and Pharmacokinetics
Together
Drug Non-competitive Antagonist
Drug Competitive Antagonist
Drug PartialAgonist
Drug Alone
Effective Dose
Biological Effect
Drug Concentration
26Some Homework
- Be familiar with the following terms
- Bioavailability
- Therapeutic Index